Home
Calyxo

Calyxo Market Share Analysis for June 2026

generate solar power with thin film solar panels of calyxo. made in germany | contact ☎ +49 3494 368 980 0

Heavy Industry and Engineering > Energy Industry

Domaincalyxo.com

Year Founded2005

Employees51 - 200

Annual Revenue$15M - $25M

Calyxo

Calyxo (including company regionals)

calyxo.com

See more website traffic and engagement information

Calyxo Revenue up to June 2026 is 15M - 25M

revenue generated by Calyxo top domains

Calyxo top domains revenue over 3 years

Revenue for Calyxo top domains

calyxo.com15M - 25M

See more with Sales Intelligence

Total visits to Calyxo's top domains

Understand Calyxo market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Calyxo's top domains

Analyze Calyxo engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Calyxo's top domains

See how Calyxo keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Calyxo top competitors by domain

Top similar sites in June 2026, ranked by their affinity

avancis.deCompany NameAvancisEmployees201 - 500HQGermany, TorgauAnnual revenue$50M - $75MTotal visits839Heavy Industry and Engineering > Energy Industry

Top technologies used by Calyxo

These are the website technologies, by industry, used by Calyxo top domains

Widget (3)

Google Maps

Advertising (2)

DoubleClick

Conversion & Analytics (2)

Google Analytics

Marketing (2)

Google Marketing Platform

More Technologies

6

See all

News & Signals from Calyxo

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsCalyxo GmbH is developing technologies to help treat kidney stone disease.In addition to growing its workforce and expanding the availability of the CVAC system, Calyxo is also planning to develop other new technologies to help treat kidney stone disease, according to Luke Düster, chief investment officer of Calyxo backer CRG.

NewsCalyxo GmbH receives financing of $32.7M in Series C.Calyxo, Inc., a medical device company focused on improving care for patients with kidney stones by delivering next generation treatment solutions, has announced the closing of a $32.7 million Series C financing round led by Questa Capital and CRG.